Challenges and possible solutions to colorectal cancer screening for the underserved

Journal of the National Cancer Institute

Volumn 106, Issue 4, 2014, Pages

  Gupta, Samir ^a,b   Sussman, Daniel A ^c,f   Doubeni, Chyke A ^d,e   Anderson, Daniel S ^q   Day, Lukejohn ^g   Deshpande, Amar R ^c   Joseph Elmunzer, B ^h   Laiyemo, Adeyinka O ⁱ   Mendez, Jeanette ^j   Somsouk, Ma ^g   Allison, James ^g,k   Bhuket, Taft ^l   Geng, Zhuo ^m   Green, Beverly B ⁿ   Itzkowitz, Steven H ^o   Martinez, Maria Elena ^b,p  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f KAISER PERMANENTE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

ⁱ HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^j MD   (United States)

^k DIVISION OF RESEARCH   (United States)

^l ALAMEDA COUNTY MEDICAL CENTER   (United States)

^m UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁿ GROUP HEALTH RESEARCH INSTITUTE   (United States)

^o MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COLONOSCOPY; COLORECTAL TUMOR; CONSENSUS; EARLY DIAGNOSIS; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MALE; MASS SCREENING; MEDICAID; MEDICALLY UNINSURED; METHODOLOGY; MIDDLE AGED; MIGRANT; MINORITY GROUP; MORTALITY; OCCULT BLOOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGMOIDOSCOPY; STATISTICS; UNITED STATES;

ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; CONSENSUS; EARLY DETECTION OF CANCER; EMIGRANTS AND IMMIGRANTS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MEDICAID; MEDICALLY UNDERSERVED AREA; MEDICALLY UNINSURED; MIDDLE AGED; MINORITY GROUPS; OCCULT BLOOD; QUALITY OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIGMOIDOSCOPY; UNITED STATES;

EID: 84898864070     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju032     Document Type: Review

References (69)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659-669
3. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
4. The Underserved and Health Information Technology: Issues and Opportunities. http://aspe.hhs.gov/sp/reports/2009/underserved/report. html. Accessed February 27, 2014.
5. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
6. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
7. Doubeni CA, Laiyemo AO, Major JM, et al. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2012;118(14):3636-3644.
8. Morgan JW, Cho MM, Guenzi CD, et al. Predictors of delayed-stage colo-rectal cancer: are we neglecting critical demographic information? Ann Epidemiol. 2011;21(12):914-921.
9. US Department of Health and Human Services. Healthy People 2020-Improving the Health of Americans. 2012. http://www.healthypeo-ple.gov/2020/ topicsobjectives2020/objectiveslist.aspx?topicId=5#354. Accessed February 27, 2014.
10. Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletchers RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2170-2175.
11. Centers for Disease Control and Prevention. Cancer screening-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(3):41-45.
12. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1611-1621.
13. Day LW, Espey DK, Madden E, Segal M, Terdiman J P. Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan natives in the Indian Health Service. Dig Dis Sci. 2011;56(7):2104-2113.
14. Schenck A P, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML. Trends in colorectal cancer test use in the medicare population, 1998-2005. Am J Prev Med. 2009;37(1):1-7.
15. Fan L, Mohile S, Zhang N, Fiscella K, Noyes K. Self-reported cancer screening among elderly Medicare beneficiaries: a rural-urban comparison. J Rural Health. 2012;28(3):312-319.
16. Cole A, Jackson E, Doescher M. Urban-rural disparities in colorectal cance rscreenin: cross-sectional analysis of 1998-2005 data from the Centers for Disease Control's Behavioral Risk Factor Surveillance Study. Cancer Med. 2012;1(3):350-356.
17. Bennett KJ, Probst JC, Bellinger JD. Receipt of cancer screening services: surprising results for some rural minorities. J Rural Health. 2012;28(1):63-72.
18. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev. 2012;21(5):728-736.
19. Steinwachs D, Allen JD, Barlow WE, et al. National Institutes of Health state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):663-667.
20. Parekh M, Fendrick AM, Ladabaum U. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther. 2008;27(8):697-712.
21. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739-750.
22. Richards CA, Kerker BD, Thorpe L, et al. Increased screening colonos-copy rates and reduced racial disparities in the New York Citywide campaign: an urban model. Am J Gastroenterol. 2011;106(11):1880-1886.
23. Grubbs S, Polite B, Carney Jr, J, et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Psychol. 2013; 31 (16):1928-1930.
24. Haas JS, Brawarsky P, Iyer A, et al. Association of local capacity for endos-copy with individual use of colorectal cancer screening and stage at diagnosis. Cancer. 2010;116(12):2922-2931.
25. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005;129(4):1151-1162.
26. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorec-tal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(2):389-394.
27. Benarroch-Gampel J, Sheffield KM, Lin YL, Kuo YF, Goodwin JS, Riall TS. Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res. 2012;47(3):1137-1157.
28. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorec-tal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365-1371.
29. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoi-doscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624-1633.
30. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345-2357.
31. Virgo KS, Burkhardt EA, Cokkinides VE, Ward EM. Impact of health care reform legislation on uninsured and medicaid-insured cancer patients. Cancer J. 2010;16(6):577-583.
32. Health Policy Brief: Preventive Services Without Cost Sharing. Health Affairs; 2010. http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief- id=37. Accessed February 27, 2014.
33. Jonas DE, Russell LB, Sandler RS, Chou J, Pignone M. Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study. Med Decis Making. 2008;28(1):56-65.
34. Glied S, Lleras-Muney A. Technological innovation and inequality in health. Demography. 2008;45(3):741-761.
35. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-582.
36. Holden DJ, Harris R, Porterfield DS, et al., Enhancing the use and quality of colorectal cancer screening. Evid Rep Technol Assess (Full Rep). 2010;2010(190):1-195, v.
37. James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev. 2002;11(6):529-534.
38. Gany FM, Shah SM, Changrani J. New York City's immigrant minorities. Reducing cancer health disparities. Cancer. 2006;107(8 Suppl):2071-2081.
39. Gupta S, Tong L, Allison JE, et al. Screening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2373-2379.
40. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC. Colorectal cancer screening-United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ. 2011;60(Suppl):42-46.
41. Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38(5):508-516.
42. Ward E. Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58(1):9-31.
43. Faden RR, Kass NE, Goodman SN, Pronovost P, Tunis S, Beauchamp TL. An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics. Hastings Center Report; 2013;43:S16-S27.
44. Zapka JG, Taplin SH, Solberg LI, Manos MM. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev. 2003;12(1):4-13.
45. Taplin SH, Anhang Price R, Edwards HM, et al. Introduction: understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr. 2012;2012(44):2-10.
46. Taplin SH, Rodgers AB. Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care. J Natl Cancer Inst Monogr. 2010; 2010(40):3-10.
47. Sarfaty, M. How to Increase Colorectal Cancer Screening Rates in Practice: A Primary Care Clinician's* Evidence-Based Toolbox and Guide 2008. http://www.cancer.org/acs/groups/content/documents/document/acspc-024588. pdf. Accessed March 6, 2014.
48. Plescia M, Richardson LC, Joseph D. New roles for public health in cancer screening. CA Cancer J Clin. 2012;62(4):217-219.
49. Dietrich AJ, Tobin JN, Robinson CM, et al. Telephone outreach to increase colon cancer screening in medicaid managed care organizations: a randomized controlled trial. Ann Fam Med. 2013;11(4):335-343.
50. Leone LA, Reuland DS, Lewis CL, et al. Reach, usage, and effectiveness of a medicaid patient navigator intervention to increase colorectal cancer screening, Cape Fear, North Carolina, 2011. Prev Chronic Dis. 2013;10:E82.
51. Green BB, Wang CY, Anderson ML, et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013;158(5):301-311.
52. Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immu-nochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173(18):1725-1732.
53. Walsh JM, Salazar R, Nguyen TT, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1-14.
54. Jean-Jacques M, Kaleba EO, Gatta JL, Gracia G, Ryan ER, Choucair BN. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial. Ann Fam Med. 2012;10(5):412-417.
55. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33(1):101-110.
56. Zapka J, Klabunde CN, Taplin S, Yuan G, Ransohoff D, Kobrin S. Screening colonoscopy in the US: attitudes and practices of primary care physicians. J Gen Intern Med. 2012;27(9):1150-1158.
57. Wu TY, Kao JY, Hsieh HF, et al. Effective colorectal cancer education for Asian Americans: a Michigan program. J Cancer Educ. 2010;25(2):146-152.
58. Lantz PM, Stencil D, Lippert MT, Beversdorf S, Jaros L, Remington PL. Breast and cervical cancer screening in a low-income managed care sample: the efficacy of physician letters and phone calls. Am J Public Health. 1995;85(6):834-836.
59. Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171(10):906-912.
60. Elmunzer BJ, O'Connell MT, Prendes S, et al. Improving access to colo-rectal cancer screening through medical philanthropy: feasibility of a flexible sigmoidoscopy health fair for uninsured patients. Am J Gastroenterol. 2011;106(10):1741-1746.
61. Chen LA, Santos S, Jandorf L, et al. A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol. 2008;6(4):443-450.
62. Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health. 2005;82(2):216-224.
63. Colorectal Cancer Prevention, Early Detection, and Treatment Act. http://www.govtrack.us/congress/bills/111/hr1189. Accessed February 27, 2014.
64. Percac-Lima S, Grant RW, Green AR, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211-217.
65. Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer. 2011;117(8):1745-1754
66. Katz ML, Fisher JL, Fleming K, Paskett ED. Patient activation increases colorectal cancer screening rates: a randomized trial among low-income minority patients. Cancer Epidemiol Biomarkers Prev. 2012;21(1):45-52.
67. Potter MB, Walsh JM, Yu TM, Gildengorin G, Green LW, McPhee SJ. The effectiveness of the FLU-FOBT program in primary care a randomized trial. Am J Prev Med. 2011;41(1):9-16.
68. Marquez E, Gupta S, Cryer B. Meeting the gastrointestinal needs of a culturally and linguistically diverse patient population. Clin Gastroenterol Hepatol. 2011;9(2):106-109.
69. Jandorf L, Stossel LM, Cooperman JL, et al. Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities. Cancer. 2013;119(3):612-620.